JPM vs NTRS
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
Northern Trust (NTRS) presents a stable financial profile with a Piotroski F-Score of 4/9, indicating a baseline of stability but lacking strong momentum. The stock is currently trading at $158.99, which is almost perfectly aligned with its growth-based intrinsic value of $160.82, though it sits at a significant premium to its defensive Graham Number of $112.88. While earnings growth and revenue trends are positive, the outlook is tempered by a very bearish technical trend (10/100) and negative insider sentiment. Overall, the company is fundamentally sound but appears fully valued at current levels.
Compare Another Pair
Related Comparisons
JPM vs NTRS: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Northern Trust Corporation (NTRS) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.